Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.

Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L.

PLoS One. 2014 Jul 31;9(7):e103735. doi: 10.1371/journal.pone.0103735. eCollection 2014.

2.

What the future holds for women after menopause: where we have been, where we are, and where we want to go.

Lobo RA.

Climacteric. 2014 Dec;17 Suppl 2:12-7. doi: 10.3109/13697137.2014.944497. Epub 2014 Aug 27.

PMID:
25032478
3.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
5.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.

6.

Long term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD004143. doi: 10.1002/14651858.CD004143.pub4. Review.

PMID:
22786488
7.

Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?

Purbrick B, Stranks K, Sum C, MacLennan AH.

Climacteric. 2012 Jun;15(3):288-93. doi: 10.3109/13697137.2011.635825.

PMID:
22612617
8.

Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.

Di Vita M, Zanghì A, Lanzafame S, Cavallaro A, Piccolo G, Berretta M, Grosso G, Cappellani A.

Clin Ter. 2011;162(5):451-6. Review.

PMID:
22041804
9.

Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women.

Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL.

Cancer Prev Res (Phila). 2011 Jun;4(6):840-50. doi: 10.1158/1940-6207.CAPR-10-0389. Epub 2011 Apr 19.

10.

Breast cancer in postmenopausal women after hormone therapy.

Baber R.

JAMA. 2011 Feb 2;305(5):466; author reply 466-7. doi: 10.1001/jama.2011.74. No abstract available.

PMID:
21285421
11.

Breast cancer in postmenopausal women after hormone therapy.

Hermsmeyer RK, Kaski JC, Thompson TL.

JAMA. 2011 Feb 2;305(5):466; author reply 466-7. doi: 10.1001/jama.2011.75. No abstract available.

PMID:
21285420
12.

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.

Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM, Ockene JK, O'Sullivan MJ, Hubbell FA, Chien JW, Chen C, Stefanick ML.

J Natl Cancer Inst. 2010 Sep 22;102(18):1413-21. doi: 10.1093/jnci/djq285. Epub 2010 Aug 13.

13.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

Am J Epidemiol. 2009 Jul 1;170(1):12-23. doi: 10.1093/aje/kwp115. Epub 2009 May 25.

14.

Long term hormone therapy for perimenopausal and postmenopausal women.

Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004143. doi: 10.1002/14651858.CD004143.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD004143.

PMID:
19370593
15.

The influence of endocrine treatments for breast cancer on health-related quality of life.

Buijs C, de Vries EG, Mourits MJ, Willemse PH.

Cancer Treat Rev. 2008 Nov;34(7):640-55. doi: 10.1016/j.ctrv.2008.04.001. Epub 2008 Jun 2. Review.

PMID:
18514425
16.

Postmenopausal hormones and coronary artery disease: potential benefits and risks.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:21-6. Review.

PMID:
17882668
17.

Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.

Mohandas B, Mehta JL.

Curr Opin Cardiol. 2007 Sep;22(5):434-42.

PMID:
17762545
18.

Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.

Lacey JV Jr, Leitzmann MF, Chang SC, Mouw T, Hollenbeck AR, Schatzkin A, Brinton LA.

Cancer. 2007 Apr 1;109(7):1303-11. Erratum in: Cancer. 2007 Aug 15;110(4):937.

19.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

20.

Effect of long-term hormone therapy on telomere length in postmenopausal women.

Lee DC, Im JA, Kim JH, Lee HR, Shim JY.

Yonsei Med J. 2005 Aug 31;46(4):471-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk